These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36254912)

  • 1. Effects of recombinant erythropoietin on hemoglobin levels and blood transfusion needs in patients with preoperative anemia undergoing cardiac surgery.
    Totonchi Z; Noohi F; Futuhi F; Azarfarin R; Radbin P
    Ann Card Anaesth; 2022; 25(4):466-471. PubMed ID: 36254912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non-cardiac surgery.
    Kaufner L; von Heymann C; Henkelmann A; Pace NL; Weibel S; Kranke P; Meerpohl JJ; Gill R
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012451. PubMed ID: 32790892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery.
    Yoo YC; Shim JK; Kim JC; Jo YY; Lee JH; Kwak YL
    Anesthesiology; 2011 Nov; 115(5):929-37. PubMed ID: 22027622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of human recombinant erythropoietin on reduction of homologous blood transfusion in open-heart surgery. A Japanese Multicenter study.
    Kyo S; Omoto R; Hirashima K; Eguchi S; Fujita T
    Circulation; 1992 Nov; 86(5 Suppl):II413-8. PubMed ID: 1424032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes in Patients Undergoing Cardiac Surgery Who Decline Transfusion and Received Erythropoietin Compared to Patients Who Did Not: A Matched Cohort Study.
    Duce L; Cooter ML; McCartney SL; Lombard FW; Guinn NR
    Anesth Analg; 2018 Aug; 127(2):490-495. PubMed ID: 28857800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study.
    Abdelrazik N; Fouda M
    Hematology; 2007 Dec; 12(6):533-41. PubMed ID: 17852440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative administration of recombinant human erythropoietin in patients undergoing gynecologic surgery.
    Sesti F; Ticconi C; Bonifacio S; Piccione E
    Gynecol Obstet Invest; 2002; 54(1):1-5. PubMed ID: 12297709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery.
    Madi-Jebara SN; Sleilaty GS; Achouh PE; Yazigi AG; Haddad FA; Hayek GM; Antakly MC; Jebara VA
    J Cardiothorac Vasc Anesth; 2004 Feb; 18(1):59-63. PubMed ID: 14973801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: an open-label, non randomized, pilot study.
    Santini D; Vincenzi B; La Cesa A; Virzi V; Navajas F; Malafarina V; Dicuonzo G; Cassandro R; Esposito V; Montesarchio V; Groeger AM; Tonini G
    Anticancer Res; 2005; 25(1B):669-74. PubMed ID: 15816644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human erythropoietin treatment for chemotherapy-related anemia in children.
    Varan A; Büyükpamukçu M; Kutluk T; Akyüz C
    Pediatrics; 1999 Feb; 103(2):E16. PubMed ID: 9925862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-weekly dose of epoetinum alfa in cancer patients with anemia receiving radiotherapy.
    Ots PM; Pérez AR; Carrizosa CL; Ocaña CV; de Dios Sáez Garrido J; Delgado Pérez JM
    Clin Transl Oncol; 2005 Dec; 7(11):486-92. PubMed ID: 16373059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usefulness of recombinant human erythropoietin in cardiac surgery with autologous blood transfusion].
    Takanashi S; Kohama M; Aoki K; Furuta S; Numata K
    Nihon Kyobu Geka Gakkai Zasshi; 1991 Dec; 39(12):2140-4. PubMed ID: 1774500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of an induction therapy with epoetin alfa in anemic cancer patients receiving concomitant chemotherapy.
    Cortesi E; Mancuso A; De Pasquale Ceratti A; Pizzardi N; D'Auria G; Accettura C; Beccaglia P; Bertelletti D; De Marinis F
    Oncologist; 2004; 9(4):459-68. PubMed ID: 15266099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between preoperative anemia, blood transfusion need, and postoperative complications in adult cardiac surgery, a single center contemporary experience.
    Mufti H; Alsharm F; Bahawi M; Almazmumi M; Alshaikh Y; Abushouk A; Algarni A; Jamalallail S; Almohammadi M
    J Cardiothorac Surg; 2023 Jan; 18(1):10. PubMed ID: 36611177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An induction dose of epoetin alpha of 40 000 IU daily for three consecutive days increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy.
    Mustacchi G; Ceccherini R; Dellach C; Foladore S; Milani S; Leita M; Sisto M
    Ann Oncol; 2006 Nov; 17(11):1705-8. PubMed ID: 16980603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of human recombinant erythropoietin in oncologic surgery].
    Mercuriali F
    Tumori; 1997; 83(4 Suppl 2):S16-9. PubMed ID: 9487379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of subcutaneous administration of erythropoietin on autologous blood predonation in open heart surgery: Japanese multicenter double-blinded dose-study].
    Omoto R; Kyo S; Furuse A; Hosoda Y; Eguchi S; Matsuda H; Kito Y; Hirashima K; Ogawa N
    Rinsho Kyobu Geka; 1994 Dec; 14(6):510-21. PubMed ID: 9423132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human erythropoietin in cancer-related anemia. Review of clinical evidence.
    Crawford J
    Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):41-53. PubMed ID: 12380954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies.
    Osterborg A; Brandberg Y; Molostova V; Iosava G; Abdulkadyrov K; Hedenus M; Messinger D;
    J Clin Oncol; 2002 May; 20(10):2486-94. PubMed ID: 12011126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous administration of recombinant human erythropoietin before cardiac surgery: a double-blind, multicenter trial in Japan.
    Hayashi J; Kumon K; Takanashi S; Kawashima Y; Eguchi S; Takaku F; Yamamura H
    Transfusion; 1994 Feb; 34(2):142-6. PubMed ID: 8310485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.